Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yijing decoction is a Traditional Chinese Medicine (TCM) herbal formula being evaluated for its potential to improve ovarian function in patients with diminished ovarian reserve (DOR). Developed by researchers at The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, the decoction is hypothesized to exert its therapeutic effects by modulating the intestinal microbiota. This modulation is thought to regulate the Th17/Treg immune balance in the peripheral blood, thereby addressing the immune-mediated aspects of ovarian reserve depletion. The formula is typically administered as an oral decoction and is part of ongoing clinical research to establish its efficacy and safety in reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yijing decoction.